Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1108892.RAehL8pSCUmHr3CThKKrBd51ue38O1OGiddhtfyDTcG80130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1108892.RAehL8pSCUmHr3CThKKrBd51ue38O1OGiddhtfyDTcG80130_assertion type Assertion NP1108892.RAehL8pSCUmHr3CThKKrBd51ue38O1OGiddhtfyDTcG80130_head.
- NP1108892.RAehL8pSCUmHr3CThKKrBd51ue38O1OGiddhtfyDTcG80130_assertion description "[We have previously demonstrated that oleuropein (OL) and hydroxytyrosol (HT) reduce 17?-estradiol-mediated proliferation in MCF-7 breast cancer (BC) cells without affecting the classical genomic action of estrogen receptor (ER), but activating instead the ERK1/2 pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108892.RAehL8pSCUmHr3CThKKrBd51ue38O1OGiddhtfyDTcG80130_provenance.
- NP1108892.RAehL8pSCUmHr3CThKKrBd51ue38O1OGiddhtfyDTcG80130_assertion evidence source_evidence_literature NP1108892.RAehL8pSCUmHr3CThKKrBd51ue38O1OGiddhtfyDTcG80130_provenance.
- NP1108892.RAehL8pSCUmHr3CThKKrBd51ue38O1OGiddhtfyDTcG80130_assertion SIO_000772 24019118 NP1108892.RAehL8pSCUmHr3CThKKrBd51ue38O1OGiddhtfyDTcG80130_provenance.
- NP1108892.RAehL8pSCUmHr3CThKKrBd51ue38O1OGiddhtfyDTcG80130_assertion wasDerivedFrom befree-2016 NP1108892.RAehL8pSCUmHr3CThKKrBd51ue38O1OGiddhtfyDTcG80130_provenance.
- NP1108892.RAehL8pSCUmHr3CThKKrBd51ue38O1OGiddhtfyDTcG80130_assertion wasGeneratedBy ECO_0000203 NP1108892.RAehL8pSCUmHr3CThKKrBd51ue38O1OGiddhtfyDTcG80130_provenance.